Elien Smeets
Elien Smeets
Unknown affiliation
Verified email at
Cited by
Cited by
The effect of F877L and T878A mutations on androgen receptor response to enzalutamide
S Prekovic, ME van Royen, ARD Voet, B Geverts, R Houtman, D Melchers, ...
Molecular cancer therapeutics 15 (7), 1702-1712, 2016
Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
L Spans, T Van den Broeck, E Smeets, S Prekovic, B Thienpont, ...
Oncotarget 7 (17), 24326, 2016
Validation of the Decipher test for predicting distant metastatic recurrence in men with high-risk nonmetastatic prostate cancer 10 years after surgery
T Van den Broeck, L Moris, T Gevaert, L Tosco, E Smeets, N Fishbane, ...
European urology oncology 2 (5), 589-596, 2019
The role of TET-mediated DNA hydroxymethylation in prostate cancer
E Smeets, AG Lynch, S Prekovic, T Van den Broeck, L Moris, C Helsen, ...
Molecular and cellular endocrinology 462, 41-55, 2018
Treatment-induced changes in the androgen receptor axis: Liquid biopsies as diagnostic/prognostic tools for prostate cancer
S Prekovic, T Van den Broeck, L Moris, E Smeets, F Claessens, S Joniau, ...
Molecular and Cellular Endocrinology 462, 56-63, 2018
The phenotype and function of murine bone marrow-derived dendritic cells is not affected by the absence of VDR or its ability to bind 1α, 25-dihydroxyvitamin D3
AS Vanherwegen, GB Ferreira, E Smeets, Y Yamamoto, S Kato, ...
The Journal of Steroid Biochemistry and Molecular Biology 164, 239-245, 2016
Genomic analysis of localized prostate cancer identifies AZIN1 as driver of metastatic progression.
T Van den Broeck, L Moris, T Gevaert, E Smeets, S Prekovic, C Helsen, ...
Cancer Research 78 (16), 114-114, 2018
Genomic analysis of primary high-risk prostate cancer tumors with metastatic recurrence identifies antizyme inhibitor 1 as a regulator of cancer cell migration through …
T Van Den Broeck, L Moris, T Gevaert, S Prekovic, L Tosco, E Smeets, ...
European Urology Supplements 17 (2), e84, 2018
A genomic analysis of metastases-prone localized prostate cancer in a European high-risk population
T Van Den Broeck, T Gevaert, S Prekovic, K Ong, L Tosco, L Moris, ...
European Urology Supplements 3 (16), e837-e838, 2017
The effect of F876L and T877A mutations on androgen receptor response to antagonists
S Prekovic, A Voet, M van Royen, B Geverts, A Houtsmuller, D Melchers, ...
The system can't perform the operation now. Try again later.
Articles 1–10